FOURTH AMENDMENT TO SECURITIES PURCHASE AND SECURITY AGREEMENTSecurities Purchase and Security Agreement • September 11th, 2023 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This Fourth Amendment to Securities Purchase and Security Agreement (this “Amendment”) is entered into as of September 8, 2023 (the “Amendment Effective Date”) by and among Evofem Biosciences, Inc., a Delaware corporation (the “Company”), 667, L.P., Baker Bros. Life Sciences, L.P. (each, a “Purchaser”, and collectively, the “Purchasers”), and Baker Bros. Advisors LP, as agent and collateral agent for the Purchasers (in such capacity, the “Designated Agent”).
